Trump's 'grim reaper' gets tongue-lashing from WSJ editors for obstructing cancer research
By Matthew Chapman
Published April 14, 2026 9:01 PM ET
President Donald Trump's administration got another tongue-lashing by the conservative Wall Street Journal editorial board, as yet another Health and Human Services official moves to obstruct groundbreaking cancer research.
"Food and Drug Administration biologics chief Vinay Prasad is stepping down at the end of this month after torpedoing breakthrough rare disease treatments," wrote the board, referencing a controversial figure who has been responsible for shutting down a number of promising therapies. "The grim reaper can’t leave soon enough, but he’s not leaving without kicking patients with late-stage melanoma on his way out."
Specifically, the board wrote, he and FDA commissioner Marty Makary rejected an experimental melanoma immunotherapy for a second time — cutting off a potential treatment avenue for people suffering from a lethal form of skin cancer.
https://www.rawstory.com/trump-2676717677/